+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Embla Medical hf (EMBLA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 50 Pages
  • April 2025
  • GlobalData
  • ID: 1314755
Embla Medical hf (EMBLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Embla Medical hf (Embla), formerly Ossur hf, is an orthopedic device company. It designs, develops, manufactures, and sells prosthetics, and bracing and support products. The company also has vast expertise in compression therapy. It offers ankle and foot supports, neck and spine support products and walkers; knee braces, compression socks, thighs and bandages; and an extensive range of premium lower limb prosthetics, including liners, knees, and feet. It has manufacturing facilities in the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company distributes its products through its subsidiaries and also through a network of distributors. Embla is headquartered in Reykjavik, Iceland.

Embla Medical hf Key Recent Developments

  • Feb 24, 2025: Embla Medical Appoints Andre Rocha as Executive Vice President of R&D
  • Feb 19, 2025: Embla Medical: Notice to 2025 Annual General Meeting
  • Feb 05, 2025: Embla Medical Publishes Interim Report for Q4 2024
  • Jan 09, 2025: Embla Medical hf: Conference Call Details for Q4/FY 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Embla Medical hf - Key Facts
  • Embla Medical hf - Key Employees
  • Embla Medical hf - Key Employee Biographies
  • Embla Medical hf - Major Products and Services
  • Embla Medical hf - History
  • Embla Medical hf - Company Statement
  • Embla Medical hf - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Embla Medical hf - Business Description
  • Business Segment: Bracing and Supports
  • Overview
  • Performance
  • Business Segment: Patient Care
  • Overview
  • Performance
  • Business Segment: Prosthetics
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: APAC
  • Performance
  • Geographical Segment: EMEA
  • Performance
  • R&D Overview
  • Embla Medical hf - Corporate Strategy
  • Embla Medical hf - SWOT Analysis
  • SWOT Analysis - Overview
  • Embla Medical hf - Strengths
  • Embla Medical hf - Weaknesses
  • Embla Medical hf - Opportunities
  • Embla Medical hf - Threats
  • Embla Medical hf - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Embla Medical hf, Medical Equipment, Deals By Year, 2019 to YTD 2025
  • Embla Medical hf, Medical Equipment, Deals By Type, 2019 to YTD 2025
  • Embla Medical hf, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 24, 2025: Embla Medical Appoints Andre Rocha as Executive Vice President of R&D
  • Feb 19, 2025: Embla Medical: Notice to 2025 Annual General Meeting
  • Feb 05, 2025: Embla Medical Publishes Interim Report for Q4 2024
  • Jan 09, 2025: Embla Medical hf: Conference Call Details for Q4/FY 2024
  • Nov 06, 2024: Embla Medical Announces Departure of Hildur Einarsdóttir, EVP R&D
  • Oct 22, 2024: Embla Medical Hf: Interim Report Q3 2024
  • Oct 08, 2024: Embla Medical: Conference Call Details for Q3 2024
  • Jul 23, 2024: Embla Medical Releases Interim Report for Q2 2024
  • Jul 18, 2024: Embla Medical Hf: The Centers for Medicare & Medicaid Services (CMS) Grants Extended Coverage in the U.S. For Lower-Limb Active K2 Amputee Patients to Access Bionic Prosthetic Solutions
  • Jul 09, 2024: Embla Medical: Conference Call for Q2 2024
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Embla Medical hf, Key Facts
  • Embla Medical hf, Key Employees
  • Embla Medical hf, Key Employee Biographies
  • Embla Medical hf, Major Products and Services
  • Embla Medical hf, History
  • Embla Medical hf, Subsidiaries
  • Embla Medical hf, Key Competitors
  • Embla Medical hf, Ratios based on current share price
  • Embla Medical hf, Annual Ratios
  • Embla Medical hf, Interim Ratios
  • Embla Medical hf, Medical Equipment, Deals By Year, 2019 to YTD 2025
  • Embla Medical hf, Medical Equipment, Deals By Type, 2019 to YTD 2025
  • Embla Medical hf, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Embla Medical hf, Performance Chart (2020 - 2024)
  • Embla Medical hf, Ratio Charts
  • Embla Medical hf, Medical Equipment, Deals By Year, 2019 to YTD 2025
  • Embla Medical hf, Medical Equipment, Deals by Type, 2019 to YTD 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DJO Global Inc
  • Breg Inc
  • Bauerfeind USA Inc
  • Otto Bock HealthCare GmbH
  • Thuasne Cr SRO
  • The Ohio Willow Wood Co